Juvederm ™ is a colorless injectable gel made from hyaluronic acid that is injected into the facial tissue to smooth wrinkles and folds around the nose and mouth. Hyaluronic acid is normally found in the skin and adds volume to the skin texture and provides a smoother appearance to the face.

We exclusively use the blunted microcannula technique for all injectable fillers at Omron Aesthetic Laser Institute.

Below we have our very own, Dr. Omron  treating a patient with Juvederm Filler Injections

Is It Better to Have Fillers Injected with a microcannula?

Unlike a needle, the microcannula technique has a blunt tip that moves around the blood vessels and allows the laying down of a foundation to recreate the natural fat pads and youthful contours of a beautiful face. The microcannula technique minimizes bruising, swelling, pain and all other potential complications of the filler technique compared to traditional needles and can be used for temple and eye hollowing, nasolabial folds, marionette lines, and prejowl reduction.

Frequently Asked Questions

How is it used?
Juvederm™ is injected directly into the skin where moderate to severe facial wrinkles and folds occur. Most patients need only one treatment and results last about 1 year.

What are the possible side effects?
Most side effects are mild to moderate and their duration is short lasting (7 days or less). The most common side effects are related to injection site reactions such redness, pain/tenderness, firmness, swelling, lumps and bumps, and bruising.

Are there any reasons why I should not receive Juvederm™?
People who have severe allergies marked by anaphylaxis and patients who have a history of allergies to gram positive bacterial proteins.

Important treatment considerations:
Aspirin or ibuprofen based medications may result in increased bruising and bleeding and should be discussed with Dr. Omron before treatment. Juvederm™ should be used with caution in patients who are on immunosuppressive agents.

Safety in pregnancy, breastfeeding females, or in patients under 18 years of age has not been established.